Scarica l'app Stockscreener
48.04
2.89%
-1.43
Dopo l'orario di chiusura:
48.07
0.03
+0.06%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché GPCR Giù?
Forum
Previsione
Structure Therapeutics Inc Adr Borsa (GPCR) Ultime notizie
Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY) and Atricure (ATRC) - The Globe and Mail
GPCR|Structure Therapeutics Inc|Price:49.000| - TradingKey
Form 4 Structure Therapeutics Inc ADR For: 24 July By Investing.com - Investing.com South Africa
A small-cap contender looking to challenge the weight-loss drug giants | 2026-07-24 | Investing News - Stockhouse
FMR LLC Discloses Major Beneficial Ownership Changes in Structure Therapeutics Inc. - Kalkine Media
FMR LLC funds sell 17,452 Structure Therapeutics (GPCR) ADS at $50.07 - Stock Titan
GPCR: Structure Therapeutics IncADR Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits
How Will Eli Lilly's GLP-1 Portfolio Sales Aid Upcoming Q2 Results? - TradingView
Analysts Are Bullish on These Healthcare Stocks: Dyne Therapeutics (DYN), ACADIA Pharmaceuticals (ACAD) - The Globe and Mail
Does EU Approval of Wegovy Pill Change NVO's Competitive Story? - TradingView
(GPCR) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Viking Therapeutics (NASDAQ:VKTX) stock maintains Phase 3 outlook despite 4.6% fall over the week - TechStock²
Takeover Buzz Sends Structure Therapeutics Soaring - TipRanks
Analysts Offer Insights on Healthcare Companies: Rani Therapeutics Holdings (RANI) and Fractyl Health, Inc. (GUTS) - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: Irhythm Technologies (IRTC), Merck & Company (MRK) and Viking Therapeutics (VKTX) - The Globe and Mail
Structure Therapeutics Slumps As Obesity Hype Cools - TipRanks
Form 4 Structure Therapeutics Inc ADR For: 15 July By Investing.com - Investing.com Nigeria
Structure Therapeutics (NASDAQ: GPCR) CSO exercises options and sells ADS - Stock Titan
Analysts Are Bullish on These Healthcare Stocks: Abbott Laboratories (ABT), GE Healthcare Technologies Inc (GEHC) - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: Pro Medicus Limited (OtherPMCUF) and BioNTech SE (BNTX) - The Globe and Mail
Analysts Conflicted on These Healthcare Names: Sanofi (SNY) and Johnson & Johnson (JNJ) - The Globe and Mail
NVO Rallies 11% in a Month: How Should Investors Play the Stock? - TradingView
Analysts Are Bullish on Top Healthcare Stocks: Vertex Pharmaceuticals (VRTX), Kuros Biosciences (CSBTF) - The Globe and Mail
LLY Hits Another Record High: Is the Stock Too Expensive to Buy Now? - TradingView
If You Invested $1,000 in Structure Therapeutics Inc ADR (GPCR) - Stock Titan
Analysts Are Bullish on These Healthcare Stocks: Amylyx Pharmaceuticals Inc (AMLX), Guardian Pharmacy Services, Inc. Class A (GRDN) - The Globe and Mail
GPCRStructure Therapeutics Inc ADR Options - Finviz
Lilly Up Around 7% in a Week: Should You Buy, Sell or Hold the Stock? - TradingView
Analysts Offer Insights on Technology Companies: Septerna, Inc. (SEPN) and Strategy (MSTR) - The Globe and Mail
Analysts Offer Insights on Healthcare Companies: Replimune Group (REPL) and Roche Holding AG (OtherRHHVF) - The Globe and Mail
Can Eli Lilly's New Drugs Fuel Growth Beyond Its GLP-1 Blockbusters? - TradingView
Form 4 Structure Therapeutics Inc ADR For: 29 June By Investing.com - Investing.com Nigeria
[Form 4] Structure Therapeutics Inc. Insider Trading Activity - Stock Titan
(GPCR) Risk Channels and Responsive Allocation - Stock Traders Daily
Structure Therapeutics, Inc. Sponsored ADR Actuals & Estimates (NASDAQ:GPCR) - TradingView
Form 144 Structure Therapeutics Inc. For: 25 June By Investing.com - Investing.com South Africa
[144] Structure Therapeutics Inc. SEC Filing - Stock Titan
Case Summary: Sangamo Therapeutics Chapter 11 - Bondoro
After Apogee, 3 More Biotech Buyout Targets Wall Street Can’t Stop Watching - AOL.com
Analysts Conflicted on These Healthcare Names: Phreesia (PHR) and Novo Nordisk (NVO) - The Globe and Mail
Shareholders Approve Directors, Auditors at 2026 Meeting - The Globe and Mail
Director at Structure Therapeutics (NASDAQ: GPCR) gets 39,453 options - Stock Titan
Structure Therapeutics (GPCR) director receives 39,453 share options at $15 - Stock Titan
Structure Therapeutics (GPCR) grants 39,453-share option award to director - Stock Titan
Structure Therapeutics (NASDAQ: GPCR) reports 2026 shareholder voting outcomes - Stock Titan
Wall Street Analysts Are Bullish on Top Healthcare Picks - The Globe and Mail
(GPCR) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Novo Nordisk Gains 7% in a Week: How Should Investors Play the Stock? - TradingView
Why Structure Therapeutics’ Hot Obesity Stock Is Suddenly Sinking - TipRanks
Analysts’ Top Healthcare Picks: MBX Biosciences, Inc. (MBX), Kura Oncology (KURA) - The Globe and Mail
H.C. Wainwright cuts Structure Therapeutics stock price target to $70 By Investing.com - Investing.com Canada
Analysts Offer Insights on Healthcare Companies: Incyte (INCY), Nuvalent (NUVL) and Viking Therapeutics (VKTX) - The Globe and Mail
2.44%
0.02%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):